StonvexLoading…
StonvexStonvexStonvexCore line items from PRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.41B | $2.40B | $2.34B | $2.60B |
Operating Income | $206.77M | $194.72M | $218.71M | $185.65M |
Net Income | $146.79M | $197.25M | $138.84M | $98.71M |
EPS (Diluted) | $3.59 | $4.53 | $2.98 | $1.90 |
Total Assets | $1.61B | $1.51B | $1.49B | $1.49B |
Total Liabilities | $863.99M | $863.49M | $899.92M | $921.45M |
Cash & Equivalents | $308.77M | $90.92M | $155.42M | $131.88M |
Free Cash Flow OCF − CapEx | $324.92M | $130.21M | $194.62M | $232.81M |
Shares Outstanding | 40.86M | 43.55M | 46.55M | 52.08M |